Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay

Indian Journal of Medical Microbiology

Volumn 33, Issue , 2015, Pages S46-S52

  Singhal, R ^a   Myneedu, V P ^a   Arora, J ^a   Singh, N ^a   Bhalla, M ^a   Verma, A ^a   Sarin, R ^a  

^a Department of Thoracic Surgery   (India)

Author keywords

Criterion; Line probe assay; MDR suspect; Mutation

Indexed keywords

BACTERIAL PROTEIN; INHA PROTEIN; ISONIAZID; KATG PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; GENOTYPE; GENOTYPE MTBDRPLUS ASSAY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRACTICE GUIDELINE; SMEAR; TUBERCULIN TEST; TUBERCULOSIS CONTROL; WILD TYPE; AGED; CHILD; DRUG EFFECTS; GENETICS; GENOTYPING TECHNIQUE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MICROSCOPY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; DNA MUTATIONAL ANALYSIS; EARLY DIAGNOSIS; FEMALE; GENOTYPING TECHNIQUES; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84923330514     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.150879     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5.
2. Balabanova Y, Drobniewski F, Nikolayevskyy V, Kruuner A, Malomanova N, Simak T, et al. An integrated approach to rapid diagnosis of tuberculosis and multi-drug resistance using liquid culture and rapid methods in Russia. PLoS One 2009;4:e7129.
3. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the GenoType MTBDR line probe assay for detection of resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis with low and high level resistance. J Clin Microbiol 2006;44:3659-64.
4. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multi-drug resistant tuberculosis: A meta-analysis. Eur Respir J 2008;32:1165-74.
5. Telenti A, Honore N, Bernasconi C, March J, Ortega A, Heym B, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level. J Clin Microbiol 1997;35:719-23.
6. Revised National Tuberculosis Control Programm (RNTCP), Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India. New Delhi: 2012. Available from: http://www.tbcindia.nic.in/pdfs/Guidelines/%20for%20PMDT%20in%20India%2-%20May%202012.pdf [Last accessed date on 2012 Jul 4].
7. Revised National Tuberculosis Control Programme (RNTCP), Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Laboratory Manual for Sputum Smear Microscopy. New Delhi: 2005. Available from: http://www.tbcindia.nic.in/pdfs/RNTCP%20Lab%20Network%20Guidelines.pdf [Last accessed date on 2012 Jul 4].
8. Kent PT, Kubica GP. Public health mycobacteriology, a guide for level III lab. Department of Health and Human Services, Public health services, (Center for Disease Control, Atlanta GA USA); 1985. p. 207.
9. Sharma SK, Kaushik G, Jha B, George N, Arora SK, Gupta D. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian J Med Res 2011;133:308-11.
10. Ramachandran R, Nalini S, Chandershekhar V, Dave PV, Sanghvi AS, Wares F, et al. Surveillance of drug resistant tuberculosis in the state of Gujrat, India. Int J Tuberc Lung Dis 2009;134:1154-60.
11. Parmasivan CN, Rehman F, Wares F, Sundar Mohan N, Sundar S, Devi S, et al. First and second line drug resistance patterns among previously treated tuberculosis patients in India. Int J Tuberc Lung Dis 2010;14:243-6.
12. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyda K, et al. Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis 2007-2010. Bull World Health Organ 2012;90:111-9D.
13. Barnard M, Albert H, Coetzee G, Brien R, Bosman ME. Rapid molecular screening for multi-drug resistant tuberculosis in a high-volume public health laboratory in South Africa. Int J Respir Crit Care Med 2008;177:787-92.
14. Makinen J, Marttila HJ, Marjamaki M, Viljanen MK, Soini H. Comparison of two commercially available DNA line probe assays for detection of multi-drug resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44:350-2.
15. Raveendran R, Wattal C, Oberoi JK, Goel N, Datta S, Prasad KJ. Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India. Indian J Med Microbiol 2012;30:58-63.
16. Singhal R, Arora J, Lal P, Bhalla M, Myneedu VP, Behera D. Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis. Indian J Med Res 2012;136:1044-7.
17. Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, Sy DN, et al. Validation of the GenoType MTBDRplus assay for diagnosis of multi-drug resistant tuberculosis in South Vietnam. BMC Infect Dis 2010;10:149.
18. Singh LS, Mazumder PB, Sharma GD. Analysis of mutational pattern in multidrug resistant tuberculosis (MDR TB) in a geographically isolated northeastern region of India. IOSR-J Pharm Biol Sci 2014;9:4-10.
19. Mokrousov I, Narvskaya O, Otten T, Limenschenko E, Steklova L, Vyshnevskiy B. High prevalence of katG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia 1996-2001. Antimicrob Agents Chemother 2002;46:1417-24.
20. Anek-Vorapong R, Sinthuwattanawibool C, Podewils LJ, McCarthy K, Ngamlert K, Promsarin B, et al. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infect Dis 2010;10:123.
21. Tolani MP, D'souza DT, Mistry NF. Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes inpatients from Mumbai, India. BMC Infect Dis 2012;12:9.